Table 1.
Amount of GHB (μmol/L) and 1,4-BD (μmol/L) in plasma during chronic IG administration of 1,4-BD in individual baboons. Body weights (BW) shown were obtained at the same time as blood samples. ND indicates a non-detectable level.
Baboon | BW (kg) | Condition | GHB (μmol/L) | 1,4-BD (μmol/L) |
---|---|---|---|---|
HA | 36.8 | 500 mg/kg; Day 7 | 2240 | 9.0 |
PY | 21.7 | 500 mg/kg; Day 6 | 690 | 17.3 |
WL | 34.3 | 500 mg/kg; Day 7 | 1500 | 16.6 |
HA | 36.1 | 500 mg/kg; Day 17 | 2010 | 20.9 |
PY | 21.6 | 500 mg/kg; Day 21 | 603 | 6.9 |
WL | 34.4 | 500 mg/kg; Day 17 | 924 | 16.8 |
HA | 36.4 | 500 mg/kg; Day 31 | 2000 | 22.0 |
PY | 21.3 | 500 mg/kg; Day 33 | 638 | 19.3 |
WL | 34.3 | 500 mg/kg; Day 31 | 782 | 10.1 |
HA | 36.1 | 600 mg/kg; Day 7 | 1750 | 11.5 |
PY | sample missing | |||
WL | 34.1 | 600 mg/kg; Day 9 | 1470 | 10.3 |
HA | 35.2 | 600 mg/kg; Day 20 | 2300 | 37.9 |
PY | 21.2 | 600 mg/kg; Day 20 | 1290 | 13.1 |
WL | 33.8 | 600 mg/kg; Day 20 | 1950 | 18.3 |
HA | 35.3 | WD; Day 16 | 18.3 | ND |
PY | 21.8 | WD; Day 15 | 32.1 | ND |
WL | 34 | WD; Day 16 | 12.3 | ND |